Search

everythinglearnresearchcommunity

for

Search:↓

These medications for BPH have known risks and may have new side effects.

A woman's hair loss during Hepatitis C treatment with PEG-INF-a-2a and Ribavirin was reversible after stopping the medication.

Epristeride's metabolism involves key metabolites and proteins, affecting its use in doping tests.

Upadacitinib may help treat difficult cases of systemic lupus erythematosus.

Drug approvals slowed in 2Q22, but notable drugs like Amvuttra, Camzyos, and Olumiant were approved.

Doxil showed some effectiveness against advanced prostate cancer but caused severe side effects at higher doses.

5α-reductase inhibitors and alpha-1 adrenergic antagonists together effectively treat benign prostatic hyperplasia, with long-term benefits.

The DPCP/HPβCD complex improves solubility and anti-inflammatory effects for alopecia areata treatment.

GI198745 is more potent and longer-lasting than finasteride, potentially better for treating hair loss.

DPP4-positive fibroblasts play a major role in producing proteins that lead to skin fibrosis.

Diphencyprone helped most patients with alopecia areata regrow some hair.

5α-reductase inhibitors, like Finasteride and Dutasteride, help manage benign prostatic hyperplasia.

Dutasteride more effectively lowers DHT levels in men with enlarged prostates than finasteride.

Middle-aged women with dilated cardiomyopathy should be screened for antiphospholipid syndrome.

PDRN may reduce inflammation and complications in revision rhinoplasty for patients with high fibrinogen levels.

Drugs like PDEI may help hair disorders like AGA.

PDE3 inhibitor may help treat hair loss by promoting hair growth.

New treatments for prostate cancer and BPH show promise, including novel compounds that target hormone synthesis and response.

The new compound is a promising, less toxic alternative to finasteride for treating prostate issues.

Yuperio combined with bisoprolol improves heart function in patients with dilated cardiomyopathy.

Doxil is an effective, modified chemotherapy drug with a unique toxicity profile and shows promise in treating certain cancers.

PDE5 inhibitors cause earlier adverse events in BPH treatment, requiring careful monitoring.

Adding diltiazem to a beta blocker can cause dangerously slow heart rates.

The new compounds may be more effective and cheaper than current treatments for conditions like baldness.

VDDR I and II are genetic disorders affecting vitamin D use, causing rickets, with VDDR I treatable by vitamin D supplements and VDDR II needing high doses and calcium.

Both DPCP alone and with PRP are effective and safe for treating severe alopecia areata.

Prostaglandin D2 increases testosterone production in skin cells through a process involving reactive oxygen species, which could be a new target for treating hair loss and other skin conditions driven by testosterone.

Gemcitabine and Disitamab Vedotin effectively and safely reduced bladder cancer in a patient.

DPCP can help regrow hair in some people with severe alopecia.